These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 35483750)

  • 21. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Status of COVID-19 vaccination around South Asia.
    Hayat M; Uzair M; Ali Syed R; Arshad M; Bashir S
    Hum Vaccin Immunother; 2022 Dec; 18(1):2016010. PubMed ID: 35061956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers of Fibrosis in Patients with COVID-19 One Year After Hospital Discharge: A Prospective Cohort Study.
    Mulet A; Tarrasó J; Rodríguez-Borja E; Carbonell-Asins JA; Lope-Martínez A; Martí-Martinez A; Murria R; Safont B; Fernandez-Fabrellas E; Ros JA; Rodriguez-Portal JA; Andreu AL; Soriano JB; Signes-Costa J
    Am J Respir Cell Mol Biol; 2023 Sep; 69(3):321-327. PubMed ID: 36848314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of the ICF in assessing the effectiveness of magnetotherapy in patients with viral pneumonia associated with COVID-19].
    Bodrova RA; Zakamyrdina AD; Fakhrutdinov IA; Dilyan AM; Mavzyutova RR; Kuchumova TV; Yunusova ER
    Vopr Kurortol Fizioter Lech Fiz Kult; 2021; 98(5):24-31. PubMed ID: 34719905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leveraging mobile phone surveys during the COVID-19 pandemic in Ecuador and Sri Lanka: Methods, timeline and findings.
    Phadnis R; Wickramasinghe C; Zevallos JC; Davlin S; Kumarapeli V; Lea V; Lee J; Perera U; Solórzano FX; Vásconez JF
    PLoS One; 2021; 16(4):e0250171. PubMed ID: 33857226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Undergraduate perceptions on transitioning into E-learning for continuation of higher education during the COVID pandemic in a developing country: a cross-sectional study from Sri Lanka.
    Subashini N; Udayanga L; De Silva LHN; Edirisinghe JC; Nafla MN
    BMC Med Educ; 2022 Jul; 22(1):521. PubMed ID: 35780138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delirium and neuropsychological outcomes in critically Ill patients with COVID-19: a cohort study.
    Ragheb J; McKinney A; Zierau M; Brooks J; Hill-Caruthers M; Iskander M; Ahmed Y; Lobo R; Mentz G; Vlisides PE
    BMJ Open; 2021 Sep; 11(9):e050045. PubMed ID: 34535480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study.
    Hsu CM; Gupta S; Tighiouart H; Goyal N; Faugno AJ; Tariq A; Raichoudhury R; Sharma JH; Meyer L; Kshirsagar RK; Jose A; Leaf DE; Weiner DE;
    Am J Kidney Dis; 2022 Mar; 79(3):404-416.e1. PubMed ID: 34871701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.
    Douin DJ; Siegel L; Grandits G; Phillips A; Aggarwal NR; Baker J; Brown SM; Chang CC; Goodman AL; Grund B; Higgs ES; Hough CL; Murray DD; Paredes R; Parmar M; Pett S; Polizzotto MN; Sandkovsky U; Self WH; Young BE; Babiker AG; Davey VJ; Kan V; Gelijns AC; Matthews G; Thompson BT; Lane HC; Neaton JD; Lundgren JD; Ginde AA
    Am J Respir Crit Care Med; 2022 Sep; 206(6):730-739. PubMed ID: 35580040
    [No Abstract]   [Full Text] [Related]  

  • 32. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Open, Randomized, Positive Control Clinical Trial of Guluronic Acid (G2013) on SARS-CoV-2 Patients.
    Aghazadeh Z; Sanaee Delir D; Gholamrezaie HR; Sadoughi A; Nezami Asl A; Noori Sanami M; Mahdavi Gorabi A; Panahi Y; Taeb M; Razavi A; Rafia S; Naderiyan Z; Robat-Jazi B; Mirshafiey A
    Curr Drug Discov Technol; 2023; 20(4):e180423215957. PubMed ID: 37076459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chest Computed Tomography and Clinical Follow-Up of Discharged Patients with COVID-19 in Wenzhou City, Zhejiang, China.
    Liu C; Ye L; Xia R; Zheng X; Yuan C; Wang Z; Lin R; Shi D; Gao Y; Yao J; Sun Q; Wang X; Jin M
    Ann Am Thorac Soc; 2020 Oct; 17(10):1231-1237. PubMed ID: 32692945
    [No Abstract]   [Full Text] [Related]  

  • 35. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
    Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
    Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Sequelae and Postdischarge Health Care Visits Over 5 Months Follow-up Among Children Hospitalized for COVID-19 or MIS-C.
    Doshi JA; Sheils NE; Buresh J; Quinicot E; Islam N; Chen Y; Asch DA; Werner RM; Swami S
    Pediatr Infect Dis J; 2022 Dec; 41(12):e513-e516. PubMed ID: 36201673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020.
    Jeewandara C; Guruge D; Jayathilaka D; Deshan Madhusanka PA; Pushpakumara PD; Tanussiya Ramu S; Sepali Aberathna I; Saubhagya Rasikangani Danasekara DR; Pathmanathan T; Gunatilaka B; Malavige S; Dias Y; Wijayamuni R; Ogg GS; Malavige GN
    PLoS One; 2021; 16(11):e0257548. PubMed ID: 34748557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-hospitalisation respiratory and physical functions in patients with SARS-CoV-2 delta.
    Wu Q; Feng L; Li H; Huang S; Shi L; Li L; Li H; Zhang L; Yang F; Zhang Y; Wu Q
    Int J Tuberc Lung Dis; 2022 Oct; 26(10):922-928. PubMed ID: 36163659
    [No Abstract]   [Full Text] [Related]  

  • 39. Sri Lanka's early success in the containment of COVID-19 through its rapid response: Clinical & epidemiological evidence from the initial case series.
    Arambepola C; Wickramasinghe ND; Jayakody S; Hewage SA; Wijewickrema A; Gunawardena N; Dhanapala S; Prathapan S
    PLoS One; 2021; 16(7):e0255394. PubMed ID: 34324587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 in New South Wales children during 2021: severity and clinical spectrum.
    Williams P; Koirala A; Saravanos GL; Lopez LK; Glover C; Sharma K; Williams T; Carey E; Shaw N; Dickens E; Sitaram N; Ging J; Bray P; Crawford NW; McMullan B; Macartney K; Wood N; Fulton EL; Lau C; Britton PN
    Med J Aust; 2022 Sep; 217(6):303-310. PubMed ID: 35851698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.